Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
20 Dezembro 2023 - 6:30PM
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on
reducing the risk of stroke and its devastating impact, today
announced the company will be participating in the upcoming 42nd
Annual J.P. Morgan Healthcare Conference.
Management is scheduled to present on Wednesday,
January 10, 2024 at 1:30 p.m. Pacific Time. Interested parties may
access a live and archived webcast of the presentation on the
“Investors” section of the company’s website at:
https://investors.silkroadmed.com/.
About Silk Road MedicalSilk Road
Medical, Inc. (NASDAQ: SILK), is a medical device company located
in Sunnyvale, California, and Plymouth, Minnesota, that is focused
on reducing the risk of stroke and its devastating impact. The
Company has pioneered a new approach for the treatment of carotid
artery disease called TransCarotid Artery Revascularization (TCAR).
TCAR is a clinically proven procedure combining surgical principles
of neuroprotection with minimally invasive endovascular techniques
to treat blockages in the carotid artery at risk of causing a
stroke. For more information on how Silk Road Medical is delivering
brighter patient outcomes through brighter clinical thinking, visit
www.silkroadmed.com and connect on Twitter, LinkedIn and
Facebook.
Investor Contact:Marissa
BychGilmartin Groupinvestors@silkroadmed.com
Silk Road Medical (NASDAQ:SILK)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Silk Road Medical (NASDAQ:SILK)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024